Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib.
Shumilov E, Wulf G, Ströbel P, Hasenkamp J, Hellige N, Bleckmann A, Haase D, Braulke F, Jung W, Schanz J, Binder M, Trümper L, Bacher U
Research article (journal) | Peer reviewedDetails about the publication
Journal: Leukemia & lymphoma (Leuk. Lymphoma)
Volume: 57
Issue: 10
Page range: 2476-80
Status: Published
Release year: 2016 (25/02/2016)
Language in which the publication is written: English
Link to the full text: https://www.tandfonline.com/doi/abs/10.3109/10428194.2016.1151510?journalCode=ilal20
Keywords: Adenine; Adult; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Osteolysis, Essential; Piperidines; Pyrazoles; Pyrimidines; Treatment Outcome
Authors from the University of Münster
| Bleckmann, Annalen | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
| Shumilov, Evgenii | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |